Evidence map›Paper›PMID 26920069›Full record

ArticleHuman molecular genetics2016

αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.

Ana Osório Oliveira, Alexander Osmand, Tiago Fleming Outeiro, Paul Joseph Muchowski, Steven Finkbeiner

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. HSF1 and Its Role in Huntington's Disease Pathology.Advances in experimental medicine and biology · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. The noncanonical small heat shock protein HSP-17 fromThe Journal of biological chemistry · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Ana Osório OliveiraLisbon Academic Medical Center PhD Program, Cell and Molecular Neuroscience Unit, Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisbon, Portugal, Gladstone Institute for Neurological Disease, J. David Gladstone Institutes, San Francisco, CA, USA.
Alexander OsmandDepartment of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN, USA.
Tiago Fleming OuteiroCell and Molecular Neuroscience Unit, Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisbon, Portugal, CEDOC-Chronic Diseases Research Center, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal, Department of Neurodegeneration and Restorative Research, University Medical Center Goettingen, Goettingen, Germany.
Paul Joseph MuchowskiSoteria Therapeutics, San Francisco, CA, USA.
Steven FinkbeinerGladstone Institute for Neurological Disease, J. David Gladstone Institutes, San Francisco, CA, USA, Department of Neurology, Department of Physiology, University of California at San Francisco, San Francisco, CA, USA and Taube/Koret Center for Neurodegenerative Disease Research, San Francisco, CA, USA sfinkbeiner@gladstone.ucsf.edu.
Gladstone Institutes · USTaube Koret Center · USUniversity of Lisbon · PTUniversity of Tennessee at Knoxville · US

Funding

MECHANISMS OF HUNTINGTIN-INDUCED NEURODEGENERATIONR01NS039074 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2000 to 2017
$5.4M
Behavioral CoreP30NS065780 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI MUCKE, LENNART · 2011 to 2015
$4.0M
Mechanisms of Neuromuscular Repair by Schwann CellsR01NS045091 · NINDS · DREXEL UNIVERSITY · PI SON, YOUNG-JIN · 2003 to 2006
$992k
NINDS NIH HHS P30 NS065780NINDS NIH HHS R01 NS039074NINDS NIH HHS R01 NS045091
6 · The paper itself

Abstract

Huntington's disease (HD) is caused by an expanded polyglutamine (polyQ) tract in the huntingtin (htt) protein. The polyQ expansion increases the propensity of htt to aggregate and accumulate, and manipulations that mitigate protein misfolding or facilitate the clearance of misfolded proteins are predicted to slow disease progression in HD models. αB-crystallin (αBc) or HspB5 is a well-characterized member of the small heat shock protein (sHsp) family that reduces mutant htt (mhtt) aggregation and toxicity in vitro and in Drosophila models of HD. Here, we determined if overexpressing αBc in vivo modulates aggregation and delays the onset and progression of disease in a full-length model of HD, BACHD mice. Expression of sHsps in neurodegenerative disease predominantly occurs in non-neuronal cells, and in the brain, αBc is mainly found in astrocytes and oligodendrocytes. Here, we show that directed αBc overexpression in astrocytes improves motor performance in rotarod and balance beam tests and improves cognitive function in the BACHD mice. Improvement in behavioral deficits correlated with mitigation of neuropathological features commonly observed in HD. Interestingly, astrocytic αBc overexpression was neuroprotective against neuronal cell loss in BACHD brains, suggesting αBc might be acting in a non-cell-autonomous manner. At the protein level, αBc decreased the level of soluble mhtt and decreased the size of mhtt inclusions in BACHD brain. Our results support a model in which elevating astrocytic αBc confers neuroprotection through a potential non-cell-autonomous pathway that modulates mhtt aggregation and protein levels.

Indexed as

Disease Models, Animalalpha-Crystallin B ChainAnimalsAstrocytesBehavior, AnimalBrainHumansHuntingtin ProteinHuntington DiseaseMiceMice, TransgenicNeuronsPhenotypealpha-Crystallin B ChainCRYAB protein, humanHuntingtin Protein

Identifiers

PMID26920069
PMCPMC4986324
OpenAlexW2290136674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.